MBOT

Pre-mercato: 1.14 0.02 +1.79%

Microbot Medical Inc (MBOT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc

Healthcare (1173)

908-938-5561

25 RECREATION PARK DR SUITE 108, HINGHAM, MA

@microbotmedical

Prossima data di guadagno

Ultimi documenti SEC

MBOT's Discussions on Twitter

Confronta MBOT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MBOT Microbot Medical Inc	1.12	18.96M	0	-10.58M	-9.21M	-1.20
ISRG Intuitive Surgical Inc	521.96	185.91B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	226.87	65.59B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	84.89	41.99B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	228.69	33.57B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	327.56	23.72B	2.88B	499.60M	321.60M	6.74

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-01-13	Reiterato	H.C. Wainwright	Buy
2019-12-24	Reiterato	H.C. Wainwright	Buy
2018-01-31	Iniziato	Ladenburg Thalmann	Buy

Microbot Medical Inc Borsa (MBOT) Ultime notizie

Microbot Medical Inc Azioni (MBOT) Dati Finanziari

Microbot Medical Inc (MBOT)

Microbot Medical Inc Stock (MBOT) Company Profile

Confronta MBOT con altri titoli

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Microbot Medical Inc Borsa (MBOT) Ultime notizie

Comparing Inspire Medical Systems (NYSE:INSP) and Microbot Medical (NASDAQ:MBOT) - Defense World

Microbot Medical Advances with LIBERTY System Milestones - TipRanks

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY® - The Manila Times

Microbot Medical® Concludes 2024 by Achieving Key - GlobeNewswire

Microbot Medical Inc. Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY - Marketscreener.com

Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

MBOT Stock Gains Following FDA Submission of the LIBERTY System - MSN

Microbot Medical appoints new director and committee member By Investing.com - Investing.com Australia

Microbot Medical appoints new director and committee member - Investing.com

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics - Nasdaq

Advanced Robotics Are Reshaping Medicine - Nasdaq

Revolutionary Robotic Surgery System Set for FDA Review! Is the Future Here? - Robots Rising

Microbot Medical submits LIBERTY surgical robot to FDA for approval - Robot Report

Microbot Medical Inc. Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System - Marketscreener.com

Microbot Medical seeks FDA clearance for endovascular robotic system - Yahoo! Voices

Microbot Medical announces US FDA submission for commercialisation of Liberty endovascular robotic system - Vascular News

Microbot Medical Submits 510(k) for Liberty Surgical Robot to FDA - MPO-mag

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access - The Bakersfield Californian

Microbot Medical's Revolutionary Disposable Robotic Surgery System Awaits FDA Decision - StockTitan

Microbot Medical Advances with LIBERTY® FDA Submission - TipRanks

Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times

Microbot Medical® Announces FDA Submission for the - GlobeNewswire

Microbot Medical Files FDA Application for Revolutionary Disposable Robotic Surgery System - StockTitan

Microbot Medical (STU:CY9D) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com

MBOT (Microbot Medical) EPS without NRI : $-0.80 (TTM As of Sep. 2024) - GuruFocus.com

Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Microbot Medical (MBOT) Stock Price, News & Analysis - MarketBeat

Microbot Medical’s Liberty Robot Study Draws to a Close - MPO-mag

Microbot Medical Releases Investor Presentation Materials - TipRanks

Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com

Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance

Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex

Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia

CMR Surgical wins FDA nod for surgical robot Versius - Medical Device Network

Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network

Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News

Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com

Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks

Microbot Medical Announces the Successful Completion of its - GlobeNewswire

Microbot Medical faces Nasdaq delisting over share price - Investing.com India

Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Microbot Medical nears end of pivotal clinical trial - Investing.com

Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network

Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks

Microbot Medical Inc. Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial - Marketscreener.com

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian

Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan

Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Microbot Medical Inc Azioni (MBOT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MBOT